FP-receptor gene silencing ameliorates myocardial fibrosis and protects from diabetic cardiomyopathy

Journal of Molecular Medicine

Volumn 92, Issue 6, 2014, Pages 629-640

  Ding, Wen Yuan ^a   Liu, Lin ^a   Wang, Zhi Hao ^a   Tang, Meng Xiong ^a   Ti, Yun ^a   Han, Lu ^a   Zhang, Lei ^a   Zhang, Yun ^a   Zhong, Ming ^a   Zhang, Wei ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Diabetic cardiomyopathy; FP receptor gene silencing; Myocardial fibrosis; Protein kinase C; Rho kinase

Indexed keywords

CHOLESTEROL; COLLAGEN TYPE 1; COLLAGEN TYPE 2; GLUCOSE; INSULIN; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN F2 ALPHA F PROSTANOID RECEPTOR; PROSTANOID RECEPTOR; PROTEIN KINASE B; PROTEIN KINASE C; RHO KINASE; SHORT HAIRPIN RNA; STREPTOZOCIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; PROSTAGLANDIN F2ALPHA RECEPTOR; PROSTAGLANDIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CELL DENSITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DOWN REGULATION; ENZYME PHOSPHORYLATION; FLUID INTAKE; FOOD INTAKE; GENE SILENCING; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART RATE; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LIPID DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; URINE VOLUME; WESTERN BLOTTING; ANIMAL; BLOOD; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC CARDIOMYOPATHIES; GENETICS; HEART MUSCLE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC CARDIOMYOPATHIES; DIET, HIGH-FAT; GENE SILENCING; MALE; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROSTAGLANDIN;

EID: 84901587095     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-013-1119-9     Document Type: Article

References (23)

1. Goyal B, Mehta A (2013) Diabetic cardiomyopathy: pathophysiological mechanisms and cardiac dysfunction. Hum Exp Toxicol 32:571-590
2. Poornima IG, Parikh P, Shannon RP (2006) Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res 98:596-605
3. Li CJ, Lv L, Li H (2012) Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid. Cardiovasc Diabetol 11:11-73
4. Creemers EE, Pinto YM (2011) Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc Res 89:265-272
5. Ti Y, Xie GL, Wang ZH, Bi XL, Ding WY, Wang J, Jiang GH, Bu PL, Zhang Y, Zhong M et al (2011) TRB3 gene silencing alleviates diabetic cardiomyopathy in a type 2 diabetic rat model. Diabetes 60:2963-2974
6. Witteles RM, Fowler MB (2008) Insulin-resistant cardiomyopathy clinical evidence, mechanisms and treatment options. J Am Coll Cardiol 51:93-102
7. Gogg S, Smith U, Jansson PA (2009) Increased MAPK activation and impaired insulin signaling in subcutaneous microvascular endothelial cells in type 2 diabetes: the role of endothelin-1. Diabetes 58:2238-2245
8. Fujino H, Srinivasan D, Regan JW (2002) Cellular conditioning and activation of beta-catenin signaling by the FPB prostanoid receptor. J Biol Chem 277:48786-48795
9. Olman MA (2009) Beyond TGF-β: a prostaglandin promotes fibrosis. Nat Med 15:1360-13618
10. Oga T, Matsuoka T, Yao C, Nonomura K, Kitaoka S, Sakata D, Kita Y, Tanizawa K, Taguchi Y, Chin K et al (2009) Prostaglandin F (2alpha) receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-beta. Nat Med 15:1426-1430
11. Guo CM, Kasaraneni N, Sun K, Myatt L (2012) Cross talk between PKC and CREB in the induction of COX-2 by PGF2α in human amnion fibroblasts. Endocrinology 53:4938-4944
12. Slater SJ, Seiz JL, Stagliano BA, Stubbs CD (2001) Interaction of protein kinase C isozymes with Rho GTP kinases. Biochemistry 40:4437-4445
13. Wygrecka M, Dahal BK, Kosanovic D, Petersen F, Taborski B, von Gerlach S, Didiasova M, Zakrzewicz D, Preissner KT, Schermuly RT et al (2013) Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: role of transmembrane SCF and the PAR-2/PKC-α/Raf-1/p44/42 signaling pathway. Am J Pathol 182:2094-2108
14. Jia ng C, Huang H, Liu J, Wang Y, Lu Z, Xu Z (2012) Fasudil, a rho-kinase inhibitor, attenuates bleomycin-induced pulmonary fibrosis in mice. Int J Mol Sci 13:8293-8307
15. Ding WY, Ti Y, Wang J, Wang ZH, Xie GL, Shang YY, Tang MX, Zhang Y, Zhang W, Zhong M (2012) Prostaglandin F2α facilitates collagen synthesis in cardiac fibroblasts via an F-prostanoid receptor/protein kinase C/Rho kinase pathway independent of transforming growth factor β1. Int J Biochem Cell Biol 44:1031-1039
16. Kanda T, Hayashi K, Wakino S, Homma K, Yoshioka K, Hasegawa K, Sugano N, Tatematsu S, Takamatsu I, Mitsuhashi T et al (2005) Role of Rho-kinase and p27 in angiotensin II-induced vascular injury. Hypertension 45:724-729
17. Xia Z, Kuo KH, Nagareddy PR, Wang F, Guo Z, Guo T, Jiang J, McNeill JH (2007) N-acetylcysteine attenuates PKCbeta2 overexpression and myocardial hypertrophy in streptozotocin-induced diabetic rats. Cardiovasc Res 73:770-782
18. Liu PY, Chen JH, Lin LJ, Liao JK (2007) Increased Rho kinase activity in a Taiwanese population with metabolic syndrome. J Am Coll Cardiol 49:1619-1624
19. Bertrand L, Horman S, Beauloye C, Vanoverschelde JL (2008) Insulin signalling in the heart. Cardiovasc Res 79:238-248
20. Osorio-Fuentealba C, Contreras-Ferrat AE, Altamirano F, Espinosa A, Li Q, Niu W, Lavandero S, Klip A, Jaimovich E (2013) Electrical stimuli release ATP to increase GLUT4 translocation and glucose uptake via PI3Kγ-Akt-AS160 in skeletal muscle cells. Diabetes 62:1519-1526
21. Hu S, Chang Y, Wang J, Xue C, Shi D, Xu H, Wang Y (2013) Fucosylated chondroitin sulfate from Acaudina molpadioides improves hyperglycemia via activation of PKB/GLUT4 signaling in skeletal muscle of insulin resistant mice. Food Funct 4:1639-1646
22. Marcus Y, Shefer G, Sasson K, Kohen F, Limor RB, Pappo O, Nevo Nito I, Bach M, Berkutzki T, Fridkin M et al (2013) Angiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model. Diabetes 62:1121-1130
23. Goupil E, Wisehart V, Khoury E, Zimmerman B, Jaffal S, Hébert TE, Laporte SA (2012) Biasing the prostaglandin F2α receptor responses toward EGFR-dependent transactivation of MAPK. Mol Endocrinol 26:1189-1202